Blog
RSS FeedPosted by Michael Wonder on 22 Jul 2021
COVID-19 vaccine weekly safety report (22 July 2021)
22 July 2021 - Over the last week, four additional cases of blood clots with low blood platelets have been assessed ...
Posted by Michael Wonder on 20 Jul 2021
Streamlining proprietary ingredient categories
20 July 2021 - To help make the medicines application process more efficient, the TGA no longer allocates proprietary ingredient ...
Posted by Michael Wonder on 20 Jul 2021
Clinical trial national approach will benefit patients and our economy
20 July 2021 - Medicines Australia welcomes the clinical trial ‘one-stop-shop’ consultation, recently announced by the Australian Commission on Safety ...
Posted by Michael Wonder on 15 Jul 2021
ATAGI update following weekly COVID-19 meeting (14 July 2021)
15 July 2021 - An update from the Australian Technical Advisory Group on Immunisation (ATAGI) following their weekly meeting on 14 ...
Posted by Michael Wonder on 15 Jul 2021
COVID-19 vaccine weekly safety report (15 July 2021)
15 July 2021 - Seven additional cases of blood clots with low blood platelets have been assessed as thrombosis with thrombocytopenia ...
Posted by Michael Wonder on 14 Jul 2021
Prescription medicines: applications under evaluation (July 2021 update)
14 July 2021 - The TGA has updated its list of applications for new medicines/vaccines or new uses for existing medicines/vaccines ...
Posted by Michael Wonder on 13 Jul 2021
ATAGI statement on use of COVID-19 vaccines in an outbreak setting
13 July 2021 - A statement from the Australian Technical Advisory Group on Immunisation (ATAGI) on the use of COVID-19 vaccines ...
Posted by Michael Wonder on 08 Jul 2021
ATAGI update following weekly COVID-19 meeting – 7 July 2021
8 July 2021 - An update from the Australian Technical Advisory Group on Immunisation following their weekly meeting on 7 July ...
Posted by Michael Wonder on 08 Jul 2021
COVID-19 vaccine weekly safety report (8 July 2021)
8 July 2021 - Seven additional cases of blood clots with low blood platelets have been assessed as thrombosis with thrombocytopenia ...
Posted by Michael Wonder on 05 Jul 2021
Statement for health care professionals: how COVID-19 vaccines are regulated for safety and effectiveness
5 July 2021 - Joint Statement from the International Coalition of Medicines Regulatory Authorities and World Health Organization. ...
Posted by Michael Wonder on 05 Jul 2021
Medical devices reforms: enhancements to post-market monitoring
5 July 2021 - This project has been established to enhance the adverse event reporting processes. ...
Posted by Michael Wonder on 01 Jul 2021
COVID-19 vaccine weekly safety report (1 July 2021)
1 July 2021 - Five additional cases of blood clots with low blood platelets have been assessed as thrombosis with thrombocytopenia ...
Posted by Michael Wonder on 28 Jun 2021
COVID-19 vaccine weekly safety report (24 June 2021)
24 June 2021 - Five additional cases of blood clots with low blood platelets have been assessed as thrombosis with thrombocytopenia ...
Posted by Michael Wonder on 26 Jun 2021
TGA grants third provisional approval to COVID-19 vaccine: Janssen
25 June 2021 - On 25 June 2021, the TGA granted provisional approval to Janssen-Cilag for its COVID-19 vaccine Janssen, ...
Posted by Michael Wonder on 24 Jun 2021
TGA grants provisional determination for the Moderna COVID-19 vaccine, Elasomeran
24 June 2021 - Today, the Therapeutic Goods Administration granted provisional determination to Moderna Australia in relation to the COVID-19 ...